International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2024
Indexing Partners
Cutting Edge Diagnostic Methods for Early Diagnoses of Breast Cancer
Author(s) | Ekta. A Andriyas, Abhishek Verma, Arun Kumar Saxena, Munzali Hamishu Umar, Imran Hussain |
---|---|
Country | India |
Abstract | Breast cancer has a lengthy history; the Egyptians were the first to record cases of the disease over 3500 years ago, around 1500 B.C. Worldwide, breast cancer is the most common cancer and the leading cause of cancer-related deaths in women. Asia is the region responsible for 43% of newly diagnosed cases and 50% of all breast cancer deaths globally. Lung cancer is no longer the primary cause of cancer incidence worldwide; breast cancer in women has surpassed it entirely, accounting for 11.7% of all cancer cases with a projected 2.3 million new cases in 2020. With a prevalence incidence of 25.8 instances per 100,000 people, breast cancer is the most frequent cancer in India. In 2020, it will be responsible for 13.6% of all new cancer cases and around 13.3 fatalities per 100,000 people. In 2020, there was 13.3 fatalities per 100,000 persons. When breast cancer is discovered at stage IV as opposed to stage I, the survival rate drops by 2.7 times, and in 2020, about 90,408 Indian women lost their lives as a consequence. In developing nations, breast cancer remains the leading cause of cancer-related mortality for women. The consensus on the causes of cancer is that smoking and alcohol consumption are to blame. However, the reality remains that it is diverse, and if identified early on, it can be treated favorably with a better-than-expected prognosis and even a lower death rate. Additionally, a wealth of scientific evidence supports the notion that 30% of cancers are curable if identified early and treated promptly, 40% are preventable, and the remaining 30% of advanced cancers are treated with palliative care due to the necessity of effective pain relief measures. According to the American Cancer Society, 281,550 women are expected to receive a breast cancer diagnosis in 2021, and 43,600 women are expected to lose their lives to the disease in the US. Early identification of diseases is essential for Individuals with smaller tumors at the time of diagnosis have a much lower chance of dying and a greater survival rate, indicating an effective therapy and expected prognosis. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. |
Keywords | early Diagnosis, Breast Cancer, Malignancy, Cancer Markers |
Field | Medical / Pharmacy |
Published In | Volume 6, Issue 3, May-June 2024 |
Published On | 2024-06-08 |
Cite This | Cutting Edge Diagnostic Methods for Early Diagnoses of Breast Cancer - Ekta. A Andriyas, Abhishek Verma, Arun Kumar Saxena, Munzali Hamishu Umar, Imran Hussain - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.21946 |
DOI | https://doi.org/10.36948/ijfmr.2024.v06i03.21946 |
Short DOI | https://doi.org/gtzjpn |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.